Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Micronutrient risk with GLP-1 receptor and dual incretin agonists in obesity: Mechanistic pathways, clinical signals, and a monitoring framework
Obesity pillars, 2026;19:100290
Efficacy and safety of incretin-based therapies in patients with type 2 diabetes mellitus: a network meta-analysis based on clinical trials
Frontiers in pharmacology, 2026;17:1846714
The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration
Frontiers in endocrinology, 2026;17:1822475
Acute Unilateral NAION following Tirzepatide Therapy: A Case Report
Case reports in ophthalmology, 2026;17(1):806-813
Weight-Lowering Drugs and Natural Female Fertility-A Systematic Review and Meta-Analysis
Clinical obesity;16(4):e70092
Pityriasis Lichenoides et Varioliformis Acuta Associated With Tirzepatide: A First Report
Journal of diabetes;18(6):e70233
Semaglutide and Risk of Adult-Onset Seizure: A Target Trial Emulation
Neurology, 2026;107(1):e218174
Selecting Pharmacologic Interventions for MASH
Digestive diseases and sciences, 2026
Pharmacotherapy for Children and Adolescents With Overweight or Obesity: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
Diabetes, obesity & metabolism, 2026
A Computational Trial of Dermal Mechanotransduction in GLP-1 Receptor Agonist-Associated Premature Facial Ageing
Aesthetic plastic surgery, 2026
Adjunctive GLP1 Receptor Agonists in Patients with Inflammatory Bowel Diseases and Obesity and/or Diabetes: A Target Trial Emulation
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2026
1-year outcomes of semaglutide, tirzepatide, and sleeve gastrectomy in obesity in type 2 diabetes: a retrospective cohort study
The lancet. Diabetes & endocrinology, 2026
Aesthetic Use of Poly-L-Lactic Acid and Hyaluronic Acid Fillers in Medication-Driven Weight Loss Due to GLP-1 Receptor Agonists: Real-World Case Series from Latin America
Clinical, cosmetic and investigational dermatology, 2026;19:620566
ATR-FTIR spectroscopy coupled with multivariate analysis for monitoring degradation and secondary structure transitions in therapeutic peptide formulations
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2026;363(Pt 1):128280
Pharmacological mechanisms and clinical impacts of antidiabetic drugs on colorectal cancer risk: a systematic review
Frontiers in pharmacology, 2026;17:1849647
Beyond weight loss: predictors of treatment satisfaction and patient-reported outcomes in incretin-based therapies. A cross-sectional study
Frontiers in endocrinology, 2026;17:1864209
Off-label GLP-1 receptor agonist and tirzepatide use for weight loss: patient safety and regulatory oversight
Annals of medicine and surgery (2012), 2026;88(7):3948-3950
Understanding reasons for initiation and experience with tirzepatide among individuals with obesity or overweight: Results from the PERCEPTIONS survey
Obesity pillars, 2026;19:100288
[Weight Recurrence After Bariatric Surgery: Definitions, Diagnosis, and Management Strategies. Part 2]
Revista medica de Chile, 2026;154(4):564-576
Inflammation-mediated facial nodules to compounded tirzepatide
JAAD case reports, 2026;75:215